0.22
+0(+0.00%)
Currency In USD
Address
4330 La Jolla Village Drive
San Diego, CA 92122
United States of America
Phone
855 293 2639
Sector
Healthcare
Industry
Biotechnology
Employees
58
First IPO Date
June 19, 2020
| Name | Title | Pay | Year Born |
| Mr. Aditya P. Mohanty M.B.A. | Chief Executive Officer & Director | 984,136 | 1967 |
| Mr. Clarke Neumann J.D. | Senior Vice President, General Counsel & Secretary | 724,615 | 1964 |
| Mr. Eric d'Esparbes | Chief Financial Officer | 748,259 | 1968 |
| Dr. Paul Shabram M.B.A. | Head of Technical Operations | 0 | N/A |
| Mr. Kevin Howe Ph.D. | Senior Vice President of Strategic Operations | 0 | N/A |
| Mr. James Knight M.B.A. | Head of Business Development | 0 | N/A |
Biora Therapeutics, Inc., a biotechnology company, engages in developing oral biotherapeutics. The company's targeted therapeutics program uses an ingestible smart capsule for targeted delivery of therapeutics in the gastrointestinal (GI) tract to enhance the treatment of inflammatory bowel diseases; and systemic therapeutics program uses an ingestible capsule for needle-free delivery of biotherapeutics directly into the intestinal mucosa for enhanced systemic uptake. It is also developing diagnostics devices to help characterize the GI tract and diagnose GI diseases, such as small intestine bacterial overgrowth through the development of various technologies to diagnose at the site of the disease. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Biora Therapeutics, Inc. was founded in 2010 and is headquartered in San Diego, California.